Each tumor was found to exhibit high levels of transcripts encoding the AR (Figure 3E–3G) and AR-regulated genes such as KLK3/PSA and TMPRSS2, indicating an active AR transcriptional program, an important clinical finding for prioritizing therapeutic options. The gene discussed is TMPRSS2; the disease is neoplasm.